Drug Guide
Chlorpheniramine Maleate; Pseudoephedrine Hydrochloride
Classification
Therapeutic: Decongestant, Antihistamine
Pharmacological: Antihistamine (Chlorpheniramine), Sympathomimetic (Pseudoephedrine)
FDA Approved Indications
- Allergic rhinitis
- Common cold symptoms including nasal congestion, sneezing, and runny nose
Mechanism of Action
Chlorpheniramine Maleate is an H1 antihistamine that blocks histamine receptors, reducing allergy symptoms. Pseudoephedrine is a sympathomimetic agent that constricts blood vessels in the nasal mucosa, decreasing swelling and congestion.
Dosage and Administration
Adult: Typically, 4 mg of chlorpheniramine every 4-6 hours as needed; pseudoephedrine 60 mg every 4-6 hours. Dose adjustments based on clinical response.
Pediatric: Chlorpheniramine: 2-4 mg every 4-6 hours for children age 6 and over; Pseudoephedrine: 30-60 mg every 4-6 hours for children age 6 and over.
Geriatric: Start at lower doses due to increased sensitivity and risk of side effects.
Renal Impairment: Adjust dosage based on severity of impairment.
Hepatic Impairment: Use with caution; no specific dosage adjustments established.
Pharmacokinetics
Absorption: Well absorbed from gastrointestinal tract
Distribution: Widely distributed including into breast milk
Metabolism: Metabolized in the liver
Excretion: Primarily via urine
Half Life: Chlorpheniramine approximately 20 hours; Pseudoephedrine approximately 6-8 hours
Contraindications
- Hypersensitivity to antihistamines or sympathomimetics
- Serious conditions like severe hypertension, significant cardiovascular disease
- MAOI use within 14 days
Precautions
- Use with caution in patients with hypertension, glaucoma, BPH, hyperthyroidism, elderly, pregnant, or lactating women
Adverse Reactions - Common
- Drowsiness, dizziness (Common)
- Dry mouth, blurred vision (Likely)
Adverse Reactions - Serious
- Arrhythmias, hypertension, central nervous system depression (Rare)
- Paradoxical excitation in children (Rare)
Drug-Drug Interactions
- Effenor, MAOIs (risk of hypertensive crisis with pseudoephedrine)
- CNS depressants (increased sedation)
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for allergy symptoms, blood pressure, heart rate, sedation levels.
Diagnoses:
- Risk for falls due to sedation
- Ineffective airway clearance
Implementation: Administer with food if gastrointestinal upset occurs. Monitor patient response, blood pressure, and signs of adverse effects.
Evaluation: Assess symptom relief, side effects, and vital signs periodically.
Patient/Family Teaching
- Avoid operating heavy machinery or driving until response is known
- Advise about potential sedative effects and interactions with alcohol
- Instruct to rise slowly to prevent orthostatic hypotension
- Encourage reporting of any adverse effects or unusual reactions
Special Considerations
Black Box Warnings:
- Pseudoephedrine can increase blood pressure and should be used cautiously in hypertensive patients.
Genetic Factors: Poor metabolizers of certain drugs may experience increased side effects.
Lab Test Interference: N/A
Overdose Management
Signs/Symptoms: Severe dizziness, hallucinations, seizures, severe hypertension, arrhythmias
Treatment: Supportive care, activated charcoal if ingestion is recent, symptomatic treatment for blood pressure and heart rhythm abnormalities, airway management.
Storage and Handling
Storage: Store at room temperature away from moisture, heat, and light
Stability: Stable under proper storage conditions for the duration of the shelf life